********************
Modern Medicines:
New Perspectives in Pharmaceutical History
October 17-18, 2008
American Institute of the History of Pharmacy
Rennebohm Hall
University of Wisconsin
Madison, WI 53705
Email: conference@aihp.org
The evolution of the modern pharmaceutical enterprise over the long
twentieth century—from its early intersection with the image and
later the structure of scientific research, to its dramatic postwar
expansion and late-century saturation of medical and marketing media—
has implications that stretch far beyond the traditional history of
pharmacy and medicine to impact broader social, cultural, economic,
business, legal, regulatory, and political developments. This
conference seeks to foster and reflect on the growing body of
pharmaceutical scholarship across historical disciplines and
encourage novel theoretical and methodological developments by
featuring newer scholars alongside more established figures in the
field.
Some travel funds will be available for graduate students, and
established scholars interested in using the resources of the
American Institute of the History of Pharmacy can apply for travel
funds through the Sonnedecker Visiting Scholar Program of the UW-
Madison School of Pharmacy (see www.aihp.org for further
information). AIHP Conference Planning Committee: Jeremy Greene,
Dominique Tobbell, Arthur Daemmrich, Michael Flannery, Elaine Stroud,
and Greg Higby.
Registration US$95 (includes all conference activities including
reception, Continental breakfast, coffee breaks, lunch workshop, and
dinner). For registration forms and program information, please check
the website <www.aihp.org> for updates.
PRELIMINARY PROGRAM
Friday, October 17
3 PM
Introduction and Welcome
Keynote Address: Elizabeth Siegel Watkins
4 – 5:30 PM
Welcome Reception at the Ebling Library Rare Book Room
Saturday, October 18
8:30 – 10:30 AM
Panel 1: Research and Development
Judy Slinn (Strategy and structure in the pharmaceutical industry
1945-2007; The rise and fall of a business model?)
Viviane Quirk (From Laboratory Life to National Systems of
Innovation: Culture as a tool for Understanding the Evolution of the
Pharmaceutical Industry in the Twentieth Century)
Christoph Gradmann, (Magic Bullets and Moving Targets: Antibiotic
Resistance before the Event 1900-1940)
Nicolas Rasmussen, (Understanding Allied Amphetamine Use in the
Second World War)
10:45 – 12:15
Panel 2: Regulation and Governance
Mary Schaffer Conroy, (State-owned Soviet Pharmaceutical Enterprises)
Daniel P. Carpenter and Dominique Tobbell, (The Emergence and Legacy
of Bioequivalence)
Shera Moxley, (Odyssey of a Biotech Drug: Leukine, 1981-1993)
12:15 – 2:15 PM
Lunch Roundtable: Pharmaceutical History Methodology
Frank R. Lichtenberg, (The Effect of Chemotherapy Innovation on
Cancer Survival, 1991-2003)
Benoit Majerus, (How Patients Experience the Introduction of
Psychoactive Drugs, 50s and 60s)
Maki Umemura, (Between Two Cultures: Banyu Pharmaceutical Co.,
1915-2004)
Michael Oldani, (A Brief history (anthropological) of Critical
Pharmacy Studies)
2:30- 4:15 PM
Panel 3: Pharmaceutical Marketing
Andrew Godley, (Merck and the Emergence of Ethical Marketing in
Pharmaceuticals)
David Herzberg, (Direct to consumer advertising)
Kalman Applbaum, (Adoption of the Circulatory Model for Product
Development and Dissemination in the Pharmaceutical Industry)
Matthew Hersch, (Marketing Stelazine to Disturbed America, 1958-1980)
4:30-5:30 PM
Summary Session
Harry M. Marks, (The Secret Lives of Drugs: What are the questions?
What are the answers?)
Dominique Tobbell, Jeremy Greene, Arthur Daemmrich, (Wrap-up comments
from session chairs)
7:30 PM
Informal Dinner at Wisconsin’s historic Red Gym
***********************************
••••••••••
History of Pharmacy Discussion Group
Moderator: Greg Higby, American Institute of the History of Pharmacy
To subscribe or unsubscribe go to:
http://www.pharmweb.net/pwmirror/pwq/pharmwebqg.html
••••••••••
|